CAH Form 4: Officer Receives 54,537 Performance Share Units Settling Aug 15, 2025
Rhea-AI Filing Summary
Stephen M. Mason, an officer of Cardinal Health, Inc. (CAH), reported a non-cash acquisition on 08/12/2025. The filing shows 54,537 performance share units acquired that, per the explanatory note, will settle into common shares on August 15, 2025 at an effective price of $0. After this award, the report lists 89,514 shares beneficially owned following the transaction. The Form 4 was signed on behalf of the reporting person by an attorney-in-fact, James E. Barnett, on 08/12/2025. The filing identifies the reporting person as an officer with title shown as CEO, GMPD Segment.
Positive
- Acquired 54,537 performance share units that will settle into common shares on August 15, 2025, increasing reported beneficial ownership to 89,514 shares
- Timely Section 16 disclosure filed and signed (via attorney-in-fact) on 08/12/2025
Negative
- None.
Insights
TL;DR: Routine, non-cash PSU award increases an officer's ownership; governance impact is standard and not immediately market-moving.
The Form 4 documents an award of 54,537 performance share units that will settle into common shares on August 15, 2025. As a non-cash equity award, this changes beneficial ownership metrics but does not represent a market transaction or cash inflow/outflow. The filing was executed by an attorney-in-fact, which is common for insider reporting. From a governance perspective, the disclosure is timely and follows Section 16 reporting requirements; it does not, by itself, indicate any governance concerns.
TL;DR: Insider grant increases reported stake to 89,514 shares; the award settles later and carries no immediate cash impact.
The entry records 54,537 performance share units acquired on 08/12/2025 that will settle on August 15, 2025 and are shown at $0 price, consistent with compensation-based PSU awards. Beneficial ownership following the reported transaction is 89,514 shares. Because this is a compensation settlement rather than an open-market purchase or sale, it is unlikely to be material to Cardinal Health's public float or near-term share supply. The disclosure is precise about dates and settlement.
FAQ
What did Stephen M. Mason report on CAH Form 4?
What is the effective price of the reported transaction on CAH Form 4?
When will the performance share units reported for CAH settle into shares?
Who signed the Form 4 for the reporting person?
What is Stephen M. Mason's relationship to Cardinal Health in this filing?